loading

Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
25.33%
1.41
1.125 1.314 1.681 3.554
Operating Expenses
10.04%
21.97
24.42 19.15 19.77 12.61
Benefits Costs and Expenses
10.23%
21.96
24.47 18.98 18.66 13.08
Costs And Expenses
10.23%
21.96
24.47 18.98 18.66 13.08
Depreciation and Amortization
2.00%
0.049
0.05 0.053 0.081 0.134
Operating Income/Loss
10.04%
-21.97
-24.42 -19.15 -19.77 -12.61
Nonoperating Income/Loss
31.26%
1.411
1.075 1.49 2.797 3.075
Income/Loss From Continuing Operations Before Tax
11.94%
-20.55
-23.34 -17.66 -16.98 -9.53
Income/Loss From Continuing Operations After Tax
11.94%
-20.55
-23.34 -17.66 -16.98 -9.53
Net Income/Loss
11.94%
-20.55
-23.34 -17.66 -16.98 -9.53
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-78.54
- - - -
Basic Average Shares
91.33%
1.0668
12.31 12.24 12.20 0.4244
Diluted Average Shares
91.33%
1.0668
12.31 12.24 12.20 0.4244
Basic Earnings Per Share
38.42%
-1.17
-1.90 -1.44 -1.39 -0.76
Diluted Earnings Per Share
38.42%
-1.17
-1.90 -1.44 -1.39 -0.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):